KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Cost of Revenue: 2010-2025

Historic Cost of Revenue for Incyte (INCY) over the last 15 years, with Sep 2025 value amounting to $99.0 million.

  • Incyte's Cost of Revenue rose 15.13% to $99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.4 million, marking a year-over-year increase of 15.72%. This contributed to the annual value of $312.1 million for FY2024, which is 22.38% up from last year.
  • Latest data reveals that Incyte reported Cost of Revenue of $99.0 million as of Q3 2025, which was up 25.69% from $78.8 million recorded in Q2 2025.
  • Incyte's 5-year Cost of Revenue high stood at $99.0 million for Q3 2025, and its period low was $29.2 million during Q1 2021.
  • For the 3-year period, Incyte's Cost of Revenue averaged around $74.4 million, with its median value being $73.2 million (2025).
  • Data for Incyte's Cost of Revenue shows a peak YoY surged of 45.84% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Incyte's Cost of Revenue stood at $43.9 million in 2021, then surged by 34.85% to $59.2 million in 2022, then climbed by 17.90% to $69.8 million in 2023, then climbed by 26.86% to $88.5 million in 2024, then grew by 15.13% to $99.0 million in 2025.
  • Its Cost of Revenue stands at $99.0 million for Q3 2025, versus $78.8 million for Q2 2025 and $73.2 million for Q1 2025.